Regression of coronary atherosclerotic lesions after rHDL infusions in acute coronary syndrome patients as assessed by intravascular ultrasound

Trial Profile

Regression of coronary atherosclerotic lesions after rHDL infusions in acute coronary syndrome patients as assessed by intravascular ultrasound

Completed
Phase of Trial: Phase II

Latest Information Update: 29 Mar 2007

At a glance

  • Drugs CSL 111 (Primary)
  • Indications Acute coronary syndromes; Atherosclerosis
  • Focus Therapeutic Use
  • Acronyms ERASE
  • Sponsors CSL
  • Most Recent Events

    • 29 Mar 2007 Status change
    • 26 Mar 2007 Results data have been published.
    • 01 Mar 2007 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top